By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Kissei Pharmaceutical Co., Ltd. 

19-48, Yoshino

Matsumoto Cit  Nagano Prefecture  399-8710  Japan
Phone: 81-0-263-25-9081 Fax: +81-0-263-25-7899


SEARCH JOBS


Industry
Healthcare

Segment
Research





Company News
Actavis (ACT) and Kissei Pharmaceutical Co., Ltd. File Lawsuits Against Sandoz, Inc. and Hetero for Infringement of Rapaflo® Patent 6/19/2013 10:29:15 AM
MediciNova, Inc. to Receive $2.5 Million Payment From Kissei Pharmaceutical Co., Ltd. to Expand Clinical Development of the MN-221 Program 10/14/2011 7:20:55 AM
MediciNova, Inc. Announces Private Sale of Stock to Kissei Pharmaceutical Co., Ltd. 9/27/2011 10:21:39 AM
SpePharm Sells Japanese Rights for Savene(R) to Kissei Pharmaceutical Co., Ltd. 9/1/2011 10:08:01 AM
Protox Therapeutics Inc. (PRX.V) Signs $75 Million License Agreement with Kissei Pharmaceutical Co., Ltd. for Commercialization of PRX302 in Japan for BPH and Prostate Disease 4/29/2010 2:58:46 PM
Kissei Pharmaceutical Co., Ltd. Announces New Drug Application for Silodosin has been Filed with FDA 2/13/2008 12:27:33 PM
Nuon Therapeutics Inc. Completes Licensing, Supply and Collaboration Agreement on Tranilast With Kissei Pharmaceutical Co., Ltd. 7/23/2007 11:14:19 AM
Kissei Pharmaceutical Co., Ltd. and Eisai Company, Ltd. (ESALY.PK) Sign a License Agreement to Develop and Commercialize Glufast(R), a Rapid-acting Insulin Secretagogue in 10 ASEAN Countries 6/13/2007 1:14:56 PM
Kissei Pharmaceutical Co., Ltd. And Daiichi Pharmaceutical (JPN) Jointly Launch Urination Disorder Improving Drug 5/12/2006 1:25:21 PM
Kissei Pharmaceutical Co., Ltd. To License KGA, Diabetes Drug Candidate, To GlaxoSmithKline (GSK) 4/10/2006 12:23:19 PM
12
//-->